SEC Form 4 · accession 0001209191-16-128832
VIVEVE MEDICAL, INC. · VIVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Janney
Director
Period of report
Jun 17, 2016
Accepted (ET)
Jun 20, 2016 · 5:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jun 17, 2016 | P | 200,000 | $5.00 | A | 881,954 | I | See Footnotes |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The amount of securities beneficially owned following the reported transaction takes into consideration the one for eight reverse stock split which was effected by the Issuer on April 15, 2016.
- F2Directly beneficially owned by Alta Bioequities, L.P.
- F3Alta Bioequities Management, LLC is the general partner of Alta Bioequities, L.P. and may be deemed to have sole voting and investment power over the shares beneficially owned by Alta Bioequities, L.P. Daniel Janney is the Managing Director of Alta Bioequities Management, LLC. Mr. Janney disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.